AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $84.80
- 52-wk low
- $29.91
- Prev close
- $59.17
- Mkt cap
- $8.99B
- Beta
- 0.09
- P/S
- 213.1x
Smart money
Earnings
Earnings came in 7.3% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $143.0K | $6.2M | $10.7M | $25.1M |
| Cost of what it sold | $90.5M | -$459.0K | $200.0K | $154.0K |
| Gross profit | $143.0K | $6.2M | $10.5M | $25.0M |
| What it spent | ||||
| Research and development | $90.5M | $85.1M | $100.1M | $99.8M |
| Sales and admin | $52.3M | $53.7M | $50.8M | $57.6M |
| Total operating expenses | $142.7M | $139.8M | $150.9M | $157.4M |
| What was left | ||||
| Operating profit | -$142.6M | -$133.7M | -$140.4M | -$132.5M |
| Profit before tax | -$130.1M | -$122.6M | -$127.8M | -$120.9M |
| Tax | — | $180.0K | — | — |
| Net profit | -$130.1M | -$122.8M | -$127.8M | -$120.9M |
| EBITDA | -$129.1M | -$121.6M | -$126.7M | -$131.4M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
16 articles · 7 days
Coverage leans bullish
Tone of tracked coverage
Crinetics Pharmaceuticals to supplement proxy after shareholder suits ahead of $85-per-share Vertex merger
NeutralAug 19Crinetics Pharmaceuticals (CRNX) Stock Looks Overvalued Despite Strong 3 Year Returns
BearishAug 18Rice Hall James & Associates LLC Takes $7.35 Million Position in Crinetics Pharmaceuticals, Inc. $CRNX
NeutralAug 18
